Country Profile

Ethiopia

Ethiopia is a significant market for Indian pharmaceutical exports — $188M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 71% of shipments, with vaccines contributing $39.1M. The compound annual growth rate since FY2015 stands at 5.9%.

🇪🇹 $188M · 1.9× growth since FY2015 · 5.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$188M
Exports FY2025–26 DGCIS
1.9×
Growth FY2015→2026
5.9%
CAGR FY2015→2026
71%
Medicines Share
4
Product Categories Supplied
Ethiopia is a significant market for Indian pharmaceutical exports — $188M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 71% of shipments, with vaccines contributing $39.1M. The compound annual growth rate since FY2015 stands at 5.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $134M (71.3%) Vaccines $39.1M (20.8%) Medicine Ingredients $7.50M (4.0%) Surgical & Hospital Supplies $7.25M (3.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Ethiopia in the RBI overseas direct investment dataset (2011–2026).